93 related articles for article (PubMed ID: 11573139)
1. Sodium/iodide symporter mRNA expression in cold thyroid nodules.
Paschke R; Neumann S
Exp Clin Endocrinol Diabetes; 2001; 109(1):45-6. PubMed ID: 11573139
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
[TBL] [Abstract][Full Text] [Related]
3. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
5. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
[TBL] [Abstract][Full Text] [Related]
6. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
7. Alterations of NIS expression in functioning thyroid nodules.
Gözü HI; Yavuzer D; Kaya H; Vural S; Sargın H; Gezen C; Sargın M; Akalın S
Kulak Burun Bogaz Ihtis Derg; 2010; 20(6):285-92. PubMed ID: 20961282
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
[TBL] [Abstract][Full Text] [Related]
10. Regulation of sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction.
Wagner S; Aust G; Schott M; Scherbaum WA; Feldkamp J; Seissler J
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):398-402. PubMed ID: 12518250
[TBL] [Abstract][Full Text] [Related]
11. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
12. Sodium/iodide symporter (NIS) and cytokines.
Schumm-Draeger PM
Exp Clin Endocrinol Diabetes; 2001; 109(1):32-4. PubMed ID: 11573136
[TBL] [Abstract][Full Text] [Related]
13. The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study.
Di Cosmo C; Fanelli G; Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Vitti P; Pinchera A; Bevilacqua G; Naccarato AG; Viacava P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):544-8. PubMed ID: 16984250
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the sodium/iodide symporter by retinoids--a review.
Schmutzler C
Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
[TBL] [Abstract][Full Text] [Related]
16. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
17. New insights about the posttranscriptional mechanisms triggered by iodide excess on sodium/iodide symporter (NIS) expression in PCCl3 cells.
Serrano-Nascimento C; Calil-Silveira J; Goulart-Silva F; Nunes MT
Mol Cell Endocrinol; 2012 Feb; 349(2):154-61. PubMed ID: 22001309
[TBL] [Abstract][Full Text] [Related]
18. Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine.
Ferreira AC; Lima LP; Araújo RL; Müller G; Rocha RP; Rosenthal D; Carvalho DP
J Endocrinol; 2005 Jan; 184(1):69-76. PubMed ID: 15642784
[TBL] [Abstract][Full Text] [Related]
19. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
Wapnir IL; Goris M; Yudd A; Dohan O; Adelman D; Nowels K; Carrasco N
Clin Cancer Res; 2004 Jul; 10(13):4294-302. PubMed ID: 15240514
[TBL] [Abstract][Full Text] [Related]
20. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
